Medical Device Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Device Class, Target Therapeutic Area, and Key Geographical Regions

1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

3.1. Chapter Overview
3.2. Medical Devices: An Overview
3.2.1. History of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Medical Device Manufacturing
3.3.1. Challenges Associated with Medical Device Manufacturing
3.3.2. Role of CMOs in Medical Device Manufacturing
3.3.3. Role of Automation in Medical Device Manufacturing Process
3.4. Historical Timeline for Medical Device CMOs
3.5. Services Offered by Medical Device CMOs
3.6. Advantages Offered by Medical Device CMOs
3.7. Risks associated with Outsourcing to CMOs
3.8. Key Considerations
3.9. Concluding Remarks

4.1. Chapter Overview
4.2. General Regulatory Guidelines for Medical Devices
4.3. Regulatory Landscape in North America
4.3.1. The US Scenario
4.3.1.1. Regulatory Authority
4.3.1.2. Review / Approval Process
4.3.2. The Canadian Scenario
4.3.2.1. Regulatory Authority
4.3.2.2. Review / Approval Process
4.4. Regulatory Landscape in Europe
4.4.1. Overall Scenario
4.4.1.1. Regulatory Authority
4.4.1.2. Review / Approval Process
4.4.2. Case Study: Brexit -The UK Scenario
4.5. Regulatory Landscape in Asia-Pacific
4.5.1. The Chinese Scenario
4.5.1.1. Regulatory Authority
4.5.1.2. Review / Approval Process
4.5.2. The Japanese Scenario
4.5.2.1. Regulatory Authority
4.5.2.2. Review / Approval Process
4.5.3. The Australian Scenario
4.5.3.1. Regulatory Authority
4.5.3.2. Review / Approval Process
4.6. Comparison of Regional Regulatory Environment

5.1. Chapter Overview
5.2. Medical Device CMOs Offering Services for Therapeutic Devices
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Size of Employee Base
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Location of Manufacturing Facility
5.2.5. Analysis by Regulatory Certifications / Accreditations
5.2.6. Analysis by Production Services Offered
5.2.7. Analysis by Post-production Services Offered
5.2.8. Analysis by Other Services Offered
5.2.9. Analysis by Device Class
5.2.10. Analysis by Type of Material(s) Handled
5.2.11. Analysis by Scale of Operation
5.2.12. Leading Players

6.1. Chapter Overview
6.2. Medical Device CMOs Offering Services for Diagnostic Devices
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Size of Employee Base
6.2.3. Analysis by Location of Headquarters
6.2.4. Analysis by Location of Manufacturing Facility
6.2.5. Analysis by Regulatory Certifications / Accreditations
6.2.6. Analysis by Production Services Offered
6.2.7. Analysis by Post-Production Services Offered
6.2.8. Analysis by Other Services Offered
6.2.9. Analysis by Device Class
6.2.10. Analysis by Type of Material(s) Handled
6.2.11. Analysis by Scale of Operation
6.2.12. Leading Players

7.1. Chapter Overview
7.2. Catheters
7.2.1. Medical Device CMOs Offering Services for Catheters
7.2.2. Analysis by Year of Establishment
7.2.3. Analysis by Size of Employee Base
7.2.4. Analysis by Location of Headquarters
7.2.5. Analysis by Location of Manufacturing Facility
7.2.6. Analysis by Regulatory Certifications / Accreditations
7.2.7. Analysis by Production Services Offered
7.2.8. Analysis by Post-Production Services Offered
7.2.9. Analysis by Other Services Offered
7.2.10. Analysis by Device Class
7.2.11. Analysis by Type of Material(s) Handled
7.2.12. Analysis by Scale of Operation
7.2.13. Leading Players
7.3. Drug Delivery Devices
7.3.1. Medical Device CMOs Offering Services for Drug Delivery Devices
7.3.2. Analysis by Year of Establishment
7.3.3. Analysis by Size of Employee Base
7.3.4. Analysis by Location of Headquarters
7.3.5. Analysis by Location of Manufacturing Facility
7.3.6. Analysis by Regulatory Certifications / Accreditations
7.3.7. Analysis by Production Services Offered
7.3.8. Analysis by Post-Production Services Offered
7.3.9. Analysis by Other Services Offered
7.3.10. Analysis by Device Class
7.3.11. Analysis by Type of Material(s) Handled
7.3.12. Analysis by Scale of Operation
7.3.13. Leading Players
7.4. Other Devices
7.4.1. Medical Device CMOs Offering Services for Other Medical Devices
7.4.2. Analysis by Year of Establishment
7.4.3. Analysis by Size of Employee Base
7.4.4. Analysis by Location of Headquarters
7.4.5. Analysis by Location of Manufacturing Facility
7.4.6. Analysis by Regulatory Certifications / Accreditations
7.4.7. Analysis by Production Services Offered
7.4.8. Analysis by Post-Production Services Offered
7.4.9. Analysis by Other Services Offered
7.4.10. Analysis by Device Class
7.4.11. Analysis by Type of Material(s) Handled
7.4.12. Analysis by Scale of Operation

8.1. Chapter Overview
8.2. Benchmark Analysis: Methodology
8.3. Region-wise Benchmark Analysis
8.3.1. North America, Peer Group I
8.3.2. North America, Peer Group II
8.3.3. North America, Peer Group III
8.3.4. North America, Peer Group IV
8.3.5. North America, Peer Group V
8.3.6. North America, Peer Group VI
8.3.7. North America, Peer Group VII
8.3.8. Europe, Peer Group VIII
8.3.9. Europe, Peer Group IX
8.3.10. Europe, Peer Group X
8.3.11. Asia, Peer Group XI
8.3.12. Asia, Peer Group XII
8.4. Concluding Remarks

9.1. Chapter Overview
9.2. Overview of the Medical Device Supply Chain
9.3. Factors Affecting the Medical Device Supply Chain
9.4. Key Performance Indicators
9.5. Supply Chain Improvement Strategies
9.5.1. Optimization of Supply Chain Capabilities
9.5.2. Visible Supply Chain and Related Advantages
9.5.2.1. Augmenting Supply Chain Visibility Through Digitalization
9.5.2.2. Benefits of Digital Supply Chain
9.6. Effects of Supply Chain Optimization
9.7. Cost Analysis
9.7.1. Production-related Costs
9.7.1.1. Labor Costs
9.7.1.2. Raw Materials Related Costs
9.7.1.3. Regulatory Compliance
9.7.1.4. Technology-related Costs
9.7.2. Supply Chain-related Costs
9.7.2.1. Local Presence
9.7.2.2. Geopolitical Risk
9.7.2.3. Logistics

10.1. Chapter Overview
10.2. CMOs Headquartered in North America
10.2.1. Cirtec Medical
10.2.1.1. Company Overview
10.2.1.2. Service Portfolio
10.2.1.3. Manufacturing Capabilities and Facilities
10.2.1.3.1. Facilities located in North America
10.2.1.3.2. Facilities Located in Europe
10.2.1.4. Future Outlook
10.2.2. DynaFlex Technologies
10.2.2.1. Company Overview
10.2.2.2. Service Portfolio
10.2.2.3. Manufacturing Capabilities and Facilities
10.2.2.4. Future Outlook
10.2.3. I-Tek Medical Technologies
10.2.3.1. Company Overview
10.2.3.2. Service Portfolio
10.2.3.3. Manufacturing Capabilities and Facilities
10.2.3.4. Future Outlook
10.2.4. Keystone Solutions Group
10.2.4.1. Company Overview
10.2.4.2. Service portfolio
10.2.4.3. Manufacturing Facilities
10.2.4.4. Future Outlook
10.2.5. Oscor
10.2.5.1. Company Overview
10.2.5.2. Service Portfolio
10.2.5.3. Manufacturing Capabilities and facilities
10.2.5.4. Future Outlook
10.2.6. SMC
10.2.6.1. Company Overview
10.2.6.2. Service Portfolio
10.2.6.3. Manufacturing Capabilities and facilities
10.2.6.3.1. Facilities Located in North America
10.2.6.3.2. Facility Located in Central America
10.2.6.3.3. Facility Located in Europe
10.2.6.3.4. Facility Located in Asia
10.2.6.4. Future Outlook
10.2.7. Stellartech Research
10.2.7.1. Company Overview
10.2.7.2. Service Portfolio
10.2.7.3. Manufacturing Capabilities and facilities
10.2.7.4. Future Outlook
10.3. CMOs Headquartered in Europe
10.3.1. Creganna Medical
10.3.1.1. Company Overview
10.3.1.2. Service Portfolio
10.3.1.3. Manufacturing Facilities
10.3.1.3.1. Facilities Located in North America
10.3.1.3.2. Facilities Located in Central America
10.3.1.3.3. Facilities Located in Europe
10.3.1.3.4. Facilities Located in Asia
10.3.1.4. Future Outlook
10.3.2. Europlaz Technologies
10.3.2.1. Company Overview
10.3.2.2. Service Portfolio
10.3.2.3. Manufacturing facilities
10.3.2.4. Future Outlook
10.3.3. Riverside Medical Packaging
10.3.3.1. Company Overview
10.3.3.2. Service Portfolio
10.3.3.3. Manufacturing Facilities
10.3.3.4. Future Outlook
10.3.4. Synecco
10.3.4.1. Company Overview
10.3.4.2. Service Portfolio
10.3.4.3. Manufacturing Facilities
10.3.4.3.1. Facilities Located in Europe
10.3.4.3.2. Facilities Located in Asia
10.3.4.4. Future Outlook
10.3.5. Trelleborg Sealing Solutions
10.3.5.1. Company Overview
10.3.5.2. Service Portfolio
10.3.5.3. Manufacturing Facilities
10.3.5.3.1. Facilities Located in North America
10.3.5.3.2. Facilities Located in Europe
10.3.5.4. Future Outlook
10.4. CMOs Headquartered in Asia
10.4.1. Interplex
10.4.1.1. Company Overview
10.4.1.2. Service Portfolio
10.4.1.3. Manufacturing Facilities
10.4.1.3.1. Facilities Located in North America
10.4.1.3.2. Facilities Located in Europe
10.4.1.3.3. Facilities Located in Asia
10.4.1.4. Future Outlook
10.4.2. Modern Medical
10.4.2.1. Company Overview
10.4.2.2. Service Portfolio
10.4.2.3. Manufacturing facilities
10.4.2.4. Future Outlook
10.4.3. Providence Enterprise
10.4.3.1. Company Overview
10.4.3.2. Service Portfolio
10.4.3.3. Manufacturing Facilities
10.4.3.4. Future Outlook
10.4.4. Suzhou JenitekJenitek
10.4.4.1. Company overview
10.4.4.2. Service Portfolio
10.4.4.3. Manufacturing Facilities
10.4.4.4. Future Outlook

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Clinical Trial Analysis: Word Cloud of Trial Titles
11.4. Analysis of Clinical Trials
11.4.1. Analysis by Trial Start Year
11.4.2. Analysis by Trial Status
11.4.3. Analysis by Phase of Development
11.4.4. Analysis by Target Indication
11.4.5. Analysis by Type of Sponsor
11.4.6. Analysis by Geography
11.4.7. Analysis by Trial Start Year and Geography
11.5. Analysis of Enrolled Patient Population
11.5.1. Analysis by Trial Status
11.5.2. Analysis by Phase of Development
11.5.3. Analysis by Geography
11.6. Analysis of Focus Therapeutic Areas
11.6.1. Analysis by Type of Sponsor
11.6.2. Analysis by Geography
11.6.2.1. North American Scenario
11.6.2.2. European Scenario
11.6.2.3. Asia Pacific Scenario
11.6.2.4. Rest of the World Scenario
11.6.3. Cardiovascular Disorders
11.6.3.1. Analysis by Trial Start Year
11.6.3.2. Analysis by Type of Sponsor
11.6.3.3. Analysis by Geography
11.6.4. Oncological Disorders
11.6.4.1. Analysis by Trial Start Year
11.6.4.2. Analysis by Type of Sponsor
11.6.4.3. Analysis by Geography
11.6.5. Central Nervous System (CNS) Disorders
11.6.5.1. Analysis by Trial Start Year
11.6.5.2. Analysis by Type of Sponsor
11.6.5.3. Analysis by Geography
11.6.6. Orthopedic Disorders
11.6.6.1. Analysis by Trial Start Year
11.6.6.2. Analysis by Type of Sponsor
11.6.6.3. Analysis by Geography
11.6.7. Respiratory Disorders
11.6.7.1. Analysis by Trial Start Year
11.6.7.2. Analysis by Type of Sponsor
11.6.7.3. Analysis by Geography

12.1. Chapter Overview
12.2. Merger and Acquisition Models
12.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
12.3.1. Analysis by Year of Mergers and Acquisitions
12.3.2. Analysis by Type of Acquisition
12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
12.3.4. Analysis by Key Value Drivers
12.3.4.1. Continent-wise distribution
12.3.4.2. Intercontinental and Intracontinental Deals
12.3.4.3. Country-wise distribution
12.3.5. Ownership Change Matrix
12.3.6. Acquisitions Made by Medical Device Companies
12.3.6.1. Acquisition of Entire Company
12.3.6.1.1. Analysis by Key Value Drivers
12.3.6.1.2. Analysis by Key Value Drivers and Year of Acquisition
12.3.6.1.3. Analysis by Type of Services Offered
12.3.6.1.4. Analysis by Type of Device
12.3.6.1.5. Analysis by Therapeutic Area
12.3.6.2. Acquisition of Company Assets
12.3.6.2.1. Analysis by Key Value Drivers
12.3.6.2.2. Analysis by Key Value Drivers and Year of Acquisition
12.3.7. Acquisition by Private Equity Firms
12.3.7.1. Analysis by Year of Acquisition
12.3.7.2. Analysis by Type of Acquisition
12.3.7.3. Analysis by Type of Device
12.3.7.4. Analysis by Therapeutic Area
12.4. Key Acquisitions: Deal Multiples
12.4.1. Analysis by Revenues

13.1. Chapter Overview
13.2. Emerging Markets: Definitions and Key Regions
13.3. Role of Emerging Markets in Industrial Manufacturing
13.3.1. Contributions to the Automobile Industry
13.3.2. Contributions to the Aerospace and Defense Industries
13.4. Medical Devices Manufacturing in Emerging Markets
13.4.1. The US-Chinese Scenario
13.4.2. Partnership with Companies in Emerging Markets
13.5. Multinational Companies Focused on Manufacturing Medical Devices in Emerging Markets
13.6. Business Models for Medical Device Manufacturing in Emerging Markets
13.6.1. Case Studies
13.6.1.1. Study A: Overview
13.6.1.1.1. Value Proposition
13.6.1.1.2. Value Creation
13.6.1.2. Study B: Overview
13.6.1.2.1. Value Proposition
13.6.1.2.2. Value Creation
13.7. Key Challenges related to Innovation in the Medical Device Industry
13.7.1. Limitations of In-House Innovation
13.8. Advantages of Establishing Innovation Hubs in Emerging Markets
13.8.1. Challenges and Market Restraints
13.8.2. Strategies to Address Existing Challenges
13.9. Future Perspectives

14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Overall Medical Device Contract Manufacturing Market, till 2030
14.3.1. Medical Device Contract Manufacturing Market: Distribution by Application Areas, till 2030
14.3.1.1. Medical Device Contract Manufacturing Market for Therapeutic Devices, till 2030
14.3.1.2. Medical Device Contract Manufacturing Market for Diagnostic Devices, till 2030
14.3.1.3. Medical Device Contract Manufacturing Market for Drug Delivery Devices, till 2030
14.3.1.4. Medical Device Contract Manufacturing Market for Other Devices, till 2030
14.3.2. Medical Device Contract Manufacturing Market: Distribution by Device Class, till 2030
14.3.2.1. Medical Device Contract Manufacturing Market: Class I Devices, till 2030
14.3.2.2. Medical Device Contract Manufacturing Market: Class II Devices, till 2030
14.3.2.3. Medical Device Contract Manufacturing Market: Class III Devices, till 2030
14.3.3. Medical Device Contract Manufacturing Market: Leading Players, till 2030
14.3.4. Medical Device Contract Manufacturing Market: Distribution by Therapeutic Areas, till 2030
14.3.4.1. Medical Device Contract Manufacturing Market for Cardiovascular Disorders, till 2030
14.3.4.2. Medical Device Contract Manufacturing Market for CNS Disorders, till 2030
14.3.4.3. Medical Device Contract Manufacturing Market for Metabolic Disorders, till 2030
14.3.4.4. Medical Device Contract Manufacturing Market for Oncological Disorders, till 2030
14.3.4.5. Medical Device Contract Manufacturing Market for Orthopedic Disorders, till 2030
14.3.4.6. Medical Device Contract Manufacturing Market for Ophthalmic Disorders, till 2030
14.3.4.7. Medical Device Contract Manufacturing Market for Pain Disorders, till 2030
14.3.4.8. Medical Device Contract Manufacturing Market for Respiratory Disorders, till 2030
14.3.4.9. Medical Device Contract Manufacturing Market for Other Therapeutic Areas, till 2030
14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, till 2030
14.4.1. Medical Device Contract Manufacturing Market in North America, till 2030
14.4.1.1. Medical Device Contract Manufacturing Market in the US, till 2030
14.4.1.2. Medical Device Contract Manufacturing Market in Rest of North America, till 2030
14.4.1.3. Medical Device Contract Manufacturing Market in North America: Class I Devices, till 2030
14.4.1.4. Medical Device Contract Manufacturing Market in North America: Class II Devices, till 2030
14.4.1.5. Medical Device Contract Manufacturing Market in North America: Class III Devices, till 2030
14.4.1.6. Medical Device Contract Manufacturing Market in North America for Cardiovascular Disorders, till 2030
14.4.1.7. Medical Device Contract Manufacturing Market in North America for CNS Disorders, till 2030
14.4.1.8. Medical Device Contract Manufacturing Market in North America for Metabolic Disorders, till 2030
14.4.1.9. Medical Device Contract Manufacturing Market in North America for Oncological Disorders, till 2030
14.4.1.10. Medical Device Contract Manufacturing Market in North America for Orthopedic Disorders, till 2030
14.4.1.11. Medical Device Contract Manufacturing Market in North America for Ophthalmic Disorders, till 2030
14.4.1.12. Medical Device Contract Manufacturing Market in North America for Pain Disorders, till 2030
14.4.1.13. Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, till 2030
14.4.1.14. Medical Device Contract Manufacturing Market for Other Therapeutic Areas in North America, till 2030
14.4.2. Medical Device Contract Manufacturing Market in Europe, till 2030
14.4.2.1. Medical Device Contract Manufacturing Market in Italy, till 2030
14.4.2.2. Medical Device Contract Manufacturing Market in Germany, till 2030
14.4.2.3. Medical Device Contract Manufacturing Market in France, till 2030
14.4.2.4. Medical Device Contract Manufacturing Market in Spain, till 2030
14.4.2.5. Medical Device Contract Manufacturing Market in the UK, till 2030
14.4.2.6. Medical Device Contract Manufacturing Market in Rest of Europe, till 2030
14.4.2.7. Medical Device Contract Manufacturing Market in Europe: Class I Devices, till 2030
14.4.2.8. Medical Device Contract Manufacturing Market in Europe: Class II Devices, till 2030
14.4.2.9. Medical Device Contract Manufacturing Market in Europe: Class III Devices, till 2030
14.4.2.10. Medical Device Contract Manufacturing Market in Europe for Cardiovascular Disorders, till 2030
14.4.2.11. Medical Device Contract Manufacturing Market in Europe for CNS Disorders, till 2030
14.4.2.12. Medical Device Contract Manufacturing Market in Europe for Metabolic Disorders, till 2030
14.4.2.13. Medical Device Contract Manufacturing Market in Europe for Oncological Disorders, till 2030
14.4.2.14. Medical Device Contract Manufacturing Market in Europe for Orthopedic Disorders, till 2030
14.4.2.15. Medical Device Contract Manufacturing Market in Europe for Ophthalmic Disorders, till 2030
14.4.2.16. Medical Device Contract Manufacturing Market in Europe for Pain Disorders, till 2030
14.4.2.17. Medical Device Contract Manufacturing Market in Europe for Respiratory Disorders, till 2030
14.4.2.18. Medical Device Contract Manufacturing Market in Europe for Other Therapeutic Areas, till 2030
14.4.3. Medical Device Contract Manufacturing Market in Asia Pacific, till 2030
14.4.3.1. Medical Device Contract Manufacturing Market in China, till 2030
14.4.3.2. Medical Device Contract Manufacturing Market in Japan, till 2030
14.4.3.3. Medical Device Contract Manufacturing Market in India, till 2030
14.4.3.4. Medical Device Contract Manufacturing Market in Rest of Asia Pacific, till 2030
14.4.3.5. Medical Device Contract Manufacturing Market in Asia Pacific: Class I Devices, till 2030
14.4.3.6. Medical Device Contract Manufacturing Market in Asia Pacific: Class II Devices, till 2030
14.4.3.7. Medical Device Contract Manufacturing Market in Asia Pacific: Class III Devices, till 2030
14.4.3.8. Medical Device Contract Manufacturing Market in Asia Pacific for Cardiovascular Disorders, till 2030
14.4.3.9. Medical Device Contract Manufacturing Market in Asia Pacific for CNS Disorders, till 2030
14.4.3.10. Medical Device Contract Manufacturing Market in Asia Pacific for Metabolic Disorders, till 2030
14.4.3.11. Medical Device Contract Manufacturing Market in Asia Pacific for Oncological Disorders, till 2030
14.4.3.12. Medical Device Contract Manufacturing Market in Asia Pacific for Orthopedic Disorders, till 2030
14.4.3.13. Medical Device Contract Manufacturing Market in Asia Pacific for Ophthalmic Disorders, till 2030
14.4.3.14. Medical Device Contract Manufacturing Market in Asia Pacific for Pain Disorders, till 2030
14.4.3.15. Medical Device Contract Manufacturing Market in Asia Pacific for Respiratory Disorders, till 2030
14.4.3.16. Medical Device Contract Manufacturing Market in Asia Pacific for Other Therapeutic Areas, till 2030
14.4.4. Medical Device Contract Manufacturing Market in Rest of the World, till 2030
14.4.4.1. Medical Device Contract Manufacturing Market in Rest of the World: Class I Devices, till 2030
14.4.4.2. Medical Device Contract Manufacturing Market in Rest of the World: Class II Devices, till 2030
14.4.4.3. Medical Device Contract Manufacturing Market in Rest of the World: Class III Devices, till 2030
14.4.4.4. Medical Device Contract Manufacturing Market in Rest of the World for Cardiovascular Disorders, till 2030
14.4.4.5. Medical Device Contract Manufacturing Market in Rest of the World for CNS Disorders, till 2030
14.4.4.6. Medical Device Contract Manufacturing Market in Rest of the World for Metabolic Disorders, till 2030
14.4.4.7. Medical Device Contract Manufacturing Market in Rest of the World for Oncological Disorders, till 2030
14.4.4.8. Medical Device Contract Manufacturing Market in Rest of the World for Orthopedic Disorders, till 2030
14.4.4.9. Medical Device Contract Manufacturing Market in Rest of the World for Ophthalmic Disorders, till 2030
14.4.4.10. Medical Device Contract Manufacturing Market in Rest of the World for Pain Disorders, till 2030
14.4.4.11. Medical Device Contract Manufacturing Market in Rest of the World for Respiratory Disorders, till 2030
14.4.4.12. Medical Device Contract Manufacturing Market in Rest of the World for Other Therapeutic Areas, till 2030

15.1. Chapter Overview
15.2. Strengths
15.3. Weaknesses
15.4. Opportunities
15.5. Threats
15.6. Concluding Remarks

16.1. Chapter Overview
16.2. Key Takeaways

Figure 3.1 Historical Evolution of Medical Devices
Figure 3.2 Medical Device Manufacturing Process
Figure 3.3 Challenges Associated with Medical Device Manufacturing
Figure 3.4 Advantages of Automation
Figure 3.5 Services Offered by CMOs
Figure 3.6 Advantages of Outsourcing to CMOs
Figure 3.7 Risks Associated with Outsourcing to CMOs
Figure 3.8 Key Considerations for Selecting a CMO Partner
Figure 4.1 US FDA: Review / Approval Process
Figure 4.2 Health Canada: Review / Approval Process
Figure 4.3 Summary of CE Marking Process
Figure 4.4 Pharmaceuticals and Medical Devices Agency: Review / Approval Process
Figure 4.5 China Food and Drug Administration: Review / Approval Process
Figure 4.6 Therapeutic Goods Administration: Review / Approval Process
Figure 4.7 Bubble Analysis: Regional Regulatory Environment
Figure 5.1 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
Figure 5.2 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
Figure 5.3 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters
Figure 5.4 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility
Figure 5.5 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
Figure 5.6 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Manufacturing Services Offered
Figure 5.7 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Post-Production Services Offered
Figure 5.8 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Other Services Offered
Figure 5.9 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
Figure 5.10 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
Figure 5.11 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
Figure 6.1 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
Figure 6.2 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
Figure 6.3 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters
Figure 6.4 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility
Figure 6.5 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
Figure 6.6 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Manufacturing Services Offered
Figure 6.7 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Post-Production Services Offered
Figure 6.8 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Other Services Offered
Figure 6.9 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
Figure 6.10 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
Figure 6.11 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
Figure 7.1 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
Figure 7.2 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
Figure 7.3 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters
Figure 7.4 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility
Figure 7.5 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
Figure 7.6 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Manufacturing Services Offered
Figure 7.7 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Post-Production Services Offered
Figure 7.8 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Other Services Offered
Figure 7.9 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
Figure 7.10 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
Figure 7.11 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
Figure 7.12 Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
Figure 7.13 Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
Figure 7.14 Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters
Figure 7.15 Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility
Figure 7.16 Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
Figure 7.17 Medical Device CMOs Offering Services for Other Devices: Distribution by Manufacturing Services Offered
Figure 7.18 Medical Device CMOs Offering Services for Other Devices: Distribution by Post-Production Services Offered
Figure 7.19 Medical Device CMOs Offering Services for Other Devices: Distribution by Other Services Offered
Figure 7.20 Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
Figure 7.21 Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
Figure 7.22 Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
Figure 8.1 Benchmark Analysis: Distribution by Region and Size of Employee Base
Figure 8.2 Benchmark Analysis: North America, Peer Group I
Figure 8.3 Benchmark Analysis: North America, Peer Group II
Figure 8.4 Benchmark Analysis: North America, Peer Group III
Figure 8.5 Benchmark Analysis: North America, Peer Group IV
Figure 8.6 Benchmark Analysis: North America, Peer Group V
Figure 8.7 Benchmark Analysis: North America, Peer Group VI
Figure 8.8 Benchmark Analysis: North America, Peer Group VII
Figure 8.9 Benchmark Analysis: Europe, Peer Group VIII
Figure 8.10 Benchmark Analysis: Europe, Peer Group IX
Figure 8.11 Benchmark Analysis: Europe, Peer Group X
Figure 8.12 Benchmark Analysis: Asia, Peer Group XI
Figure 11.10 Enrolled Patient Population: Distribution by Phase of Development
Figure 11.11 Enrolled Patient Population: Distribution by Geography
Figure 11.12 Clinical Trial Analysis: Distribution by Focus Therapeutic Areas
Figure 11.13 Heat Map Analysis: Emerging Therapeutic Areas
Figure 11.14 Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
Figure 11.15 Clinical Trial Analysis: Prominent Therapeutic Areas in North America
Figure 11.16 Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
Figure 11.17 Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
Figure 11.18 Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
Figure 11.19 Clinical Trials for Cardiovascular Disorders: Distribution by Trial Start Year, Since 2018
Figure 11.20 Clinical Trials for Cardiovascular Disorders: Distribution by Sponsor Type
Figure 11.21 Clinical Trials for Cardiovascular Disorders: Distribution by Geography
Figure 11.22 Clinical Trials for Oncological Disorders: Distribution of Trials by Start Year, Since 2018
Figure 11.23 Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
Figure 11.24 Clinical Trials for Oncological Disorders: Distribution by Geography
Figure 11.25 Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, Since 2018
Figure 11.26 Clinical Trials for CNS Disorders: Distribution by Sponsor Type
Figure 11.27 Clinical Trials for CNS Disorders: Distribution by Geography
Figure 11.28 Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, Since 2018
Figure 11.29 Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
Figure 11.30 Clinical Trials for Orthopedic Disorders: Distribution by Geography
Figure 11.31 Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, Since 2018
Figure 11.32 Clinical Trials for Respiratory Disorders: Distribution by Sponsor Type
Figure 11.33 Clinical Trials for Respiratory Disorders: Distribution by Geography
Figure 12.1 Mergers and Acquisitions: Year-Wise Cumulative Trend, Since 2018
Figure 12.2 Mergers and Acquisitions: Distribution by Type of Acquisitions
Figure 12.3 Most Active Acquirers: Distribution by Number of Acquisitions
Figure 12.4 Mergers and Acquisitions: Key Value Drivers
Figure 12.5 Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Figure 12.6 Mergers and Acquisitions: Distribution by Type of Device
Figure 12.7 Heat Map Analysis: Type of Devices and Key Value Drivers
Figure 12.8 Mergers and Acquisitions: Distribution by Therapeutic Area
Figure 12.9 Mergers and Acquisitions: Distribution by Services Offered
Figure 12.10 Acquisitions: Continental Distribution
Figure 12.11 Acquisitions: Country-wise Distribution
Figure 12.12 Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 12.13 Mergers and Acquisitions: Relationship between Deal Multiples
Figure 13.1 Prominent Emerging Markets
Figure 13.2 Recommendations to Optimize Manufacturing Strategies
Figure 14.1 Overall Medical Device CMOs Market, Base Scenario, till 2035 (USD Billion)
Figure 14.2 Medical Device CMOs Market for Therapeutic Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.3 Medical Device CMOs Market for Diagnostic Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.4 Medical Device CMOs Market for Drug Delivery Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.5 Medical Device CMOs Market for Other Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.6 Medical Device CMOs Market for Class I Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.7 Medical Device CMOs Market for Class II Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.8 Medical Device CMOs Market for Class III Devices, Base Scenario, till 2035 (USD Billion)
Figure 14.9 Medical Device CMOs Market: Leading Players, till 2035 (USD Billion)
Figure 14.10 Medical Device CMOs Market for Cardiovascular Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.11 Medical Device CMOs Market for CNS Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.12 Medical Device CMOs Market for Metabolic Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.13 Medical Device CMOs Market for Oncological Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.14 Medical Device CMOs Market for Orthopedic Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.15 Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.16 Medical Device CMOs Market for Pain Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.17 Medical Device CMOs Market for Respiratory Disorders, Base Scenario, till 2035 (USD Billion)
Figure 14.18 Medical Device CMOs Market for Other Therapeutic Areas, Base Scenario, till 2035 (USD Billion)
Figure 14.19 Medical Device CMOs Market in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.20 Medical Device CMOs Market in the US, till 2035 (USD Billion)
Figure 14.21 Medical Device CMOs Market in Rest of North America, till 2035 (USD Billion)
Figure 14.22 Medical Device CMOs Market for Class I Devices in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.23 Medical Device CMOs Market for Class II Devices in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.24 Medical Device CMOs Market for Class III Devices in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.25 Medical Device CMOs Market for Cardiovascular Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.26 Medical Device CMOs Market for CNS Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.27 Medical Device CMOs Market for Metabolic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.28 Medical Device CMOs Market for Oncological Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.29 Medical Device CMOs Market for Orthopedic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.30 Medical Device CMOs Market for Ophthalmic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.31 Medical Device CMOs Market for Pain Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.32 Medical Device CMOs Market for Respiratory Disorders in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.33 Medical Device CMOs Market for Other Therapeutic Areas in North America, Base Scenario, till 2035 (USD Billion)
Figure 14.34 Medical Device CMOs Market in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.35 Medical Device CMOs Market in Italy, Base Scenario, till 2035 (USD Billion)
Figure 14.36 Medical Device CMOs Market in Germany, Base Scenario, till 2035 (USD Billion)
Figure 14.37 Medical Device CMOs Market in France, Base Scenario, till 2035 (USD Billion)
Figure 14.38 Medical Device CMOs Market in Spain, Base Scenario, till 2035 (USD Billion)
Figure 14.39 Medical Device CMOs Market in the UK, Base Scenario, till 2035 (USD Billion)
Figure 14.40 Medical Device CMOs Market in Rest of Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.41 Medical Device CMOs Market for Class I Devices in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.42 Medical Device CMOs Market for Class II Devices in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.43 Medical Device CMOs Market for Class III Devices in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.44 Medical Device CMOs Market for Cardiovascular Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.45 Medical Device CMOs Market for CNS Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.46 Medical Device CMOs Market for Metabolic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.47 Medical Device CMOs Market of Oncological Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.48 Medical Device CMOs Market for Orthopedic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.49 Medical Device CMOs Market for Ophthalmic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.50 Medical Device CMOs Market for Pain Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.51 Medical Device CMOs Market for Respiratory Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.52 Medical Device CMOs Market for Other Therapeutic Areas in Europe, Base Scenario, till 2035 (USD Billion)
Figure 14.53 Medical Device CMOs Market in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.54 Medical Device CMOs Market in China, Base Scenario, till 2035 (USD Billion)
Figure 14.55 Medical Device CMOs Market in Japan, Base Scenario, till 2035 (USD Billion)
Figure 14.56 Medical Device CMOs Market in India, Base Scenario, till 2035 (USD Billion)
Figure 14.57 Medical Device CMOs Market in Rest of Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.58 Medical Device CMOs Market for Class I Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.59 Medical Device CMOs Market for Class II Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.60 Medical Device CMOs Market for Class III Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.61 Medical Device CMOs Market for Cardiovascular Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.62 Medical Device CMOs Market for CNS Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.63 Medical Device CMOs Market for Metabolic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.64 Medical Device CMOs Market for Oncological Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.65 Medical Device CMOs Market for Orthopedic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.66 Medical Device CMOs Market for Ophthalmic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.67 Medical Device CMOs Market for Pain Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.68 Medical Device CMOs Market for Respiratory Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 14.69 Medical Device CMOs Market for Other Therapeutic Areas in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Figure 15.1 Medical Device Contract Manufacturing SWOT Analysis: Overview
Figure 15.2 Comparison of SWOT Factors: Harvey Ball Analysis

Table 4.1 Device Classification: US
Table 4.2 Device Classification: Canada
Table 4.3 HTA Processes in Canada: Provincial Requirements
Table 4.4 Regulatory Bodies in EU5 Countries
Table 4.5 Device Classification: Europe
Table 4.6 List of CE Directives in Europe
Table 4.7 Conformity Assessment Modules in Europe
Table 4.8 Device Classification: Japan
Table 4.9 Device Classification: China
Table 4.10 Device Classification: Australia
Table 4.11 Medical Devices: Regulatory Landscape Summary
Table 5.1 List of Medical Device CMOs Offering Services for Therapeutic Devices
Table 5.2 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Regulatory Certifications / Accreditations
Table 5.3 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Manufacturing Services
Table 5.4 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Post-Production Services
Table 5.5 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Other Services
Table 5.6 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Device Class
Table 5.7 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Type of Material(s) Handled
Table 5.8 Medical Device CMOs Offering Services for Therapeutic Devices: Information on Scale of Operation
Table 6.1 List of Medical Device CMOs Offering Services for Diagnostic Devices
Table 6.2 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Regulatory Certifications / Accreditations
Table 6.3 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Manufacturing Services
Table 6.4 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Post-Production Services
Table 6.5 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Other Services
Table 6.6 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Device Class
Table 6.7 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Type of Material(s) Handled
Table 6.8 Medical Device CMOs Offering Services for Diagnostic Devices: Information on Scale of Operations
Table 7.1 List of Medical Device CMOs Offering Services for Drug Delivery Devices
Table 7.2 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Regulatory Certifications / Accreditations
Table 7.3 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Manufacturing Services
Table 7.4 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Post-Production Services
Table 7.5 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Other Services
Table 7.6 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Device Class
Table 7.7 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Type of Material(s) Handled
Table 7.8 Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Scale of Operations
Table 7.9 List of Medical Device CMOs Offering Services for Other Devices
Table 7.10 Medical Device CMOs Offering Services for Other Devices: Information on Regulatory Certifications / Accreditations
Table 7.11 Medical Device CMOs Offering Services for Other Devices: Information on Manufacturing Services
Table 7.12 Medical Device CMOs Offering Services for Other Devices: Information on Post-Production Services
Table 7.13 Medical Device CMOs Offering Services for Other Devices: Information on Other Services
Table 7.14 Medical Device CMOs Offering Services for Other Devices: Information on Device Class
Table 7.15 Medical Device CMOs Offering Services for Other Devices: Information on Type of Material(s) Handled
Table 7.16 Medical Device CMOs Offering Services for Other Devices: Information on Scale of Operations
Table 8.1 Benchmark Analysis: Peer Groups
Table 10.1 Cirtec Medical: Company Overview
Table 10.2 DynaFlex Technologies: Company Overview
Table 10.3 I-Tek Medical Technologies: Company Overview
Table 10.4 Keystone Solutions Group: Company Overview
Table 10.5 Oscor: Company Overview
Table 10.6 SMC: Company Overview
Table 10.7 Stellartech: Company Overview
Table 10.8 Creganna Medical: Company Overview
Table 10.9 Europlaz Technologies: Company Overview
Table 10.10 Riverside Medical Packaging: Company Overview
Table 10.11 Synecco: Post-production Company Overview
Table 10.12 Trelleborg Sealing Solutions: Company Overview
Table 10.13 Interplex: Company Overview
Table 10.14 Modern Medical: Company Overview
Table 10.15 Providence Enterprise: Company Overview
Table 10.16 Suzhou Jenitek: Company Overview
Table 12.1 Medical Device Contract Manufacturing: List of Mergers and Acquisitions, Since 2014
Table 12.2 Mergers and Acquisitions: Key Value Drivers and Type of Devices, Since 2014
Table 12.3 Mergers and Acquisitions: Deal Multiples, Since 2013
Table 13.1 Comparative Analysis between Developed and Developing Nations
Table 13.2 Medtech A: Company Overview
Table 13.3 Medtech A: Operational Values
Table 13.4 Medtech B: Company Overview
Table 13.5 Medtech A: Operational Values
Table 18.1 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
Table 18.2 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
Table 18.3 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters
Table 18.4 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility
Table 18.5 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.6 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Manufacturing Services Offered
Table 18.7 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Post-Production Services Offered
Table 18.8 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Other Services Offered
Table 18.9 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
Table 18.10 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
Table 18.11 Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
Table 18.12 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
Table 18.13 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
Table 18.14 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters
Table 18.15 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility
Table 18.16 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.17 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Manufacturing Services Offered
Table 18.18 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Post-Production Services Offered
Table 18.19 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Other Services Offered
Table 18.20 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
Table 18.21 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
Table 18.22 Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
Table 18.23 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
Table 18.24 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
Table 18.25 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters
Table 18.26 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility
Table 18.27 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.28 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Manufacturing Services Offered
Table 18.29 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Post-Production Services Offered
Table 18.30 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Other Services Offered
Table 18.31 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
Table 18.32 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
Table 18.33 Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
Table 18.34 Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
Table 18.35 Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
Table 18.36 Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters
Table 18.37 Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility
Table 18.38 Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.39 Medical Device CMOs Offering Services for Other Devices: Distribution by Manufacturing Services Offered
Table 18.40 Medical Device CMOs Offering Services for Other Devices: Distribution by Post-Production Services Offered
Table 18.41 Medical Device CMOs Offering Services for Other Devices: Distribution by Other Services Offered
Table 18.42 Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
Table 18.43 Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
Table 18.44 Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
Table 18.45 Benchmark Analysis: Distribution by Region and Size of Employee Base
Table 18.46 Clinical Trial Analysis: Distribution by Trial Start Year, Since 2018
Table 18.47 Clinical Trial Analysis: Distribution by Trial Status
Table 18.48 Clinical Trial Analysis: Distribution by Phase of Development
Table 18.49 Clinical Trial Analysis: Top 10 Target Indication
Table 18.50 Clinical Trial Analysis: Distribution by Sponsor Type
Table 18.51 Clinical Trial Analysis: Distribution by Trial Start Year and Geography, Since 2018
Table 18.52 Enrolled Patient Population: Distribution by Trial Status
Table 18.53 Enrolled Patient Population: Distribution by Phase of Development
Table 18.54 Clinical Trial Analysis: Distribution by Focus Therapeutic Areas
Table 18.55 Heat Map Analysis: Emerging Therapeutic Areas
Table 18.56 Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
Table 18.57 Clinical Trial Analysis: Prominent Therapeutic Areas in North America
Table 18.58 Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
Table 18.59 Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
Table 18.60 Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
Table 18.61 Clinical Trials for Cardiovascular Disorders: Distribution by Trial Start Year, Since 2018
Table 18.62 Clinical Trials for Cardiovascular Disorders: Distribution by Sponsor Type
Table 18.63 Clinical Trials for Cardiovascular Disorders: Distribution by Geography
Table 18.64 Clinical Trials for Oncological Disorders: Distribution of Trials by Start Year, Since 2018
Table 18.65 Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
Table 18.66 Clinical Trials for Oncological Disorders: Distribution by Geography
Table 18.67 Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, Since 2018
Table 18.68 Clinical Trials for CNS Disorders: Distribution by Sponsor Type
Table 18.69 Clinical Trials for CNS Disorders: Distribution by Geography
Table 18.70 Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, Since 2018
Table 18.71 Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
Table 18.72 Clinical Trials for Orthopedic Disorders: Distribution by Geography
Table 18.73 Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, Since 2018
Table 18.74 Clinical Trials for Respiratory Disorders: Distribution by Sponsor Type
Table 18.75 Clinical Trials for Respiratory Disorders: Distribution by Geography
Table 18.76 Mergers and Acquisitions: Year-Wise Cumulative Trend, Since 2018
Table 18.77 Mergers and Acquisitions: Distribution by Type of Acquisitions
Table 18.78 Acquisitions: Most Active Acquirers
Table 18.79 Mergers and Acquisitions: Key Value Drivers
Table 18.80 Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Table 18.81 Mergers and Acquisitions: Distribution by Type of Devices
Table 18.82 Mergers and Acquisitions: Distribution by Therapeutic Area
Table 18.83 Mergers and Acquisitions: Distribution by Services Offered
Table 18.84 Acquisitions: Country-wise Distribution
Table 18.85 Overall Medical Device CMOs Market, Base Scenario, till 2035 (USD Billion)
Table 18.86 Medical Device CMOs Market for Therapeutic Devices, Base Scenario, till 2035 (USD Billion)
Table 18.87 Medical Device CMOs Market for Diagnostic Devices, Base Scenario, till 2035 (USD Billion)
Table 18.88 Medical Device CMOs Market for Drug Delivery Devices, Base Scenario, till 2035 (USD Billion)
Table 18.89 Medical Device CMOs Market for Other Devices, Base Scenario, till 2035 (USD Billion)
Table 18.90 Medical Device CMOs Market for Class I Devices, Base Scenario, till 2035 (USD Billion)
Table 18.91 Medical Device CMOs Market for Class II Devices, Base Scenario, till 2035 (USD Billion)
Table 18.92 Medical Device CMOs Market for Class III Devices, Base Scenario, till 2035 (USD Billion)
Table 18.93 Medical Device CMOs Market: Leading Players, till 2035 (USD Billion)
Table 18.94 Medical Device CMOs Market for Cardiovascular Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.95 Medical Device CMOs Market for CNS Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.96 Medical Device CMOs Market for Metabolic Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.97 Medical Device CMOs Market for Oncological Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.98 Medical Device CMOs Market for Orthopedic Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.99 Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.100 Medical Device CMOs Market for Pain Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.101 Medical Device CMOs Market for Respiratory Disorders, Base Scenario, till 2035 (USD Billion)
Table 18.102 Medical Device CMOs Market for Other Therapeutic Areas, Base Scenario, till 2035 (USD Billion)
Table 18.103 Medical Device CMOs Market in North America, Base Scenario, till 2035 (USD Billion)
Table 18.104 Medical Device CMOs Market in the US, till 2035 (USD Billion)
Table 18.105 Medical Device CMOs Market in Rest of North America, till 2035 (USD Billion)
Table 18.106 Medical Device CMOs Market for Class I Devices in North America, Base Scenario, till 2035 (USD Billion)
Table 18.107 Medical Device CMOs Market for Class II Devices in North America, Base Scenario, till 2035 (USD Billion)
Table 18.108 Medical Device CMOs Market for Class III Devices in North America, Base Scenario, till 2035 (USD Billion)
Table 18.109 Medical Device CMOs Market for Cardiovascular Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.110 Medical Device CMOs Market for CNS Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.111 Medical Device CMOs Market for Metabolic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.112 Medical Device CMOs Market for Oncological Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.113 Medical Device CMOs Market for Orthopedic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.114 Medical Device CMOs Market for Ophthalmic Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.115 Medical Device CMOs Market for Pain Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.116 Medical Device CMOs Market for Respiratory Disorders in North America, Base Scenario, till 2035 (USD Billion)
Table 18.117 Medical Device CMOs Market for Other Therapeutic Areas in North America, Base Scenario, till 2035 (USD Billion)
Table 18.118 Medical Device CMOs Market in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.119 Medical Device CMOs Market in Italy, Base Scenario, till 2035 (USD Billion)
Table 18.120 Medical Device CMOs Market in Germany, Base Scenario, till 2035 (USD Billion)
Table 18.121 Medical Device CMOs Market in France, Base Scenario, till 2035 (USD Billion)
Table 18.122 Medical Device CMOs Market in Spain, Base Scenario, till 2035 (USD Billion)
Table 18.123 Medical Device CMOs Market in the UK, Base Scenario, till 2035 (USD Billion)
Table 18.124 Medical Device CMOs Market in Rest of Europe, Base Scenario, till 2035 (USD Billion)
Table 18.125 Medical Device CMOs Market for Class I Devices in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.126 Medical Device CMOs Market for Class II Devices in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.127 Medical Device CMOs Market for Class III Devices in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.128 Medical Device CMOs Market for Cardiovascular Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.129 Medical Device CMOs Market for CNS Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.130 Medical Device CMOs Market for Metabolic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.131 Medical Device CMOs Market of Oncological Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.132 Medical Device CMOs Market for Orthopedic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.133 Medical Device CMOs Market for Ophthalmic Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.134 Medical Device CMOs Market for Pain Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.135 Medical Device CMOs Market for Respiratory Disorders in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.136 Medical Device CMOs Market for Other Therapeutic Areas in Europe, Base Scenario, till 2035 (USD Billion)
Table 18.137 Medical Device CMOs Market in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.138 Medical Device CMOs Market in China, Base Scenario, till 2035 (USD Billion)
Table 18.139 Medical Device CMOs Market in Japan, Base Scenario, till 2035 (USD Billion)
Table 18.140 Medical Device CMOs Market in India, Base Scenario, till 2035 (USD Billion)
Table 18.141 Medical Device CMOs Market in Rest of Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.142 Medical Device CMOs Market for Class I Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.143 Medical Device CMOs Market for Class II Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.144 Medical Device CMOs Market for Class III Devices in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.145 Medical Device CMOs Market for Cardiovascular Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.146 Medical Device CMOs Market for CNS Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.147 Medical Device CMOs Market for Metabolic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.148 Medical Device CMOs Market for Oncological Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.149 Medical Device CMOs Market for Orthopedic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.150 Medical Device CMOs Market for Ophthalmic Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.151 Medical Device CMOs Market for Pain Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.152 Medical Device CMOs Market for Respiratory Disorders in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)
Table 18.153 Medical Device CMOs Market for Other Therapeutic Areas in Asia and Rest of the World, Base Scenario, till 2035 (USD Billion)